Casalini P, Botta L, Menard S
Molecular Targeting Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, 20133 Milano, Italy.
J Biol Chem. 2001 Apr 13;276(15):12449-53. doi: 10.1074/jbc.M009732200. Epub 2001 Jan 16.
HER2 oncogene overexpression has been associated either with proliferation or differentiation and apoptosis. The role of p53 on these different chances was investigated. Wild type (wt) p53-IGROV1 cells showed growth inhibition and apoptosis after HER2 transfection, whereas no anti-proliferative effect was observed in its mutated p53 sub-line unless wt p53 was cotransfected with HER2. Stable HER2 transfectants derived from wt p53 line treated with heregulin-beta1 or epidermal growth factor showed a decrease in proliferation due to a G(2)/M cell cycle block despite normal mitogen-activated protein kinase activation. In these HER2 transfectants, c-Myc and p53 expression were increased, whereas MDM2 was dramatically down-modulated. By contrast, growth factors stimulation of HER2 transfectants with mutated-p53 induced progression through the cell cycle. Together, our data point to a regulatory role for p53 in HER2 signaling.
HER2癌基因的过表达与增殖、分化及凋亡均有关联。研究了p53在这些不同情况中的作用。野生型(wt)p53-IGROV1细胞在转染HER2后表现出生长抑制和凋亡,而在其突变型p53亚系中未观察到抗增殖作用,除非wt p53与HER2共转染。源自wt p53系的稳定HER2转染细胞在用heregulin-β1或表皮生长因子处理后,尽管有正常的丝裂原活化蛋白激酶激活,但由于G(2)/M细胞周期阻滞而导致增殖减少。在这些HER2转染细胞中,c-Myc和p53表达增加,而MDM2则显著下调。相比之下,用突变型p53刺激HER2转染细胞的生长因子可诱导细胞周期进程。总之,我们的数据表明p53在HER2信号传导中具有调节作用。